Rishi Bedi
Company: Y-Trap
Job title: Chief Executive Officer
Seminars:
Overcoming Challenges of TGF-β Targeted Therapies by Selecting Suitable Combinations to Achieve Clinical Success 12:30 pm
Investigating different potential checkpoint inhibitors (SMAD, PD1) with TGF-β targetedtherapies for the most effective patient response Advancing to the next level by using proven combination TGF-β directed therapies to show clinical efficacy Employing a multi-pronged method to turn tumors from cold to hotRead more
day: Conference Day One